SLC6A4 and depressive symptom measurement: Generally, neuroimaging studies including ligand binding to 5-HT1A receptors or the 5-HT transporter indicate a deficit in the serotonergic tone such that both disorders (depression and epilepsy) could coexist, and indeed one pathology could influence the other on this neurotransmission [135].